David Tyronne Howton
2012
In 2012, David Tyronne Howton earned a total compensation of $2.8M as Senior Vice President, General Counsel and Corporate Secretary at Sarepta Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $29,006 |
|---|---|
| Option Awards | $2,760,570 |
| Salary | $59,856 |
| Other | $459 |
| Total | $2,849,891 |
Howton received $2.8M in option awards, accounting for 97% of the total pay in 2012.
Howton also received $29K in non-equity incentive plan, $59.9K in salary and $459 in other compensation.
Rankings
In 2012, David Tyronne Howton's compensation ranked 2,449th out of 11,487 executives tracked by ExecPay. In other words, Howton earned more than 78.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,449 out of 11,487 | 79th |
Division Manufacturing | 848 out of 4,253 | 80th |
Major group Chemicals And Allied Products | 189 out of 1,203 | 84th |
Industry group Drugs | 110 out of 925 | 88th |
Industry Pharmaceutical Preparations | 89 out of 700 | 87th |
Source: SEC filing on April 30, 2013.
Howton's colleagues
We found seven more compensation records of executives who worked with David Tyronne Howton at Sarepta Therapeutics in 2012.
2012
Sandesh Mahatme
Sarepta Therapeutics
Chief Financial Officer
2012
David Howton
Sarepta Therapeutics
General Counsel
2012
Christopher Garabedian
Sarepta Therapeutics
Chief Executive Officer
2012
Edward Kaye
Sarepta Therapeutics
Chief Executive Officer
2012
Michael Jacobsen
Sarepta Therapeutics
Vice President, Finance
2012
Jayant Aphale
Sarepta Therapeutics
Senior Vice President, Technical Operations
2012
Effie Toshav
Sarepta Therapeutics